Add-onTuesday, October 20, 2026
Astorg-backed Oxoid Remel to carve out Solabia microbiology unit
Oxoid Remel, a maker of diagnostic consumables and equipment for microbiological testing, will take over the microbiology diagnostics division of fellow Astorg portfolio company Solabia.
Oxoid Remel, a supplier of diagnostic consumables and equipment used in microbiological testing, has agreed to carve out the microbiology diagnostics division of Solabia. Both companies are portfolio companies of the European private equity firm Astorg.
Astorg is the sponsor on both sides of the transaction, with Solabia selling the division to Oxoid Remel. No financial terms were disclosed.
Deal facts
- Target
- Solabia microbiology diagnostic division
- Business
- Microbiology diagnostic division of Solabia, a carve-out target supplying diagnostic consumables and equipment
- Acquirer
- Oxoid Remel
- Backed by
- Astorg
- Seller
- Solabia (Astorg portfolio company)
- Deal type
- Add-on
- Status
- Announced, not yet closed
- Announced
- Tuesday, October 20, 2026
Sources
- PEI Private EquityOct 20, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.